{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:18:31Z","timestamp":1785403111151,"version":"3.56.0"},"reference-count":73,"publisher":"American Association for Cancer Research (AACR)","issue":"3","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"publisher","award":["Internal"],"award-info":[{"award-number":["Internal"]}],"id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["Discovery Boost Grant"],"award-info":[{"award-number":["Discovery Boost Grant"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["HL065095-25"],"award-info":[{"award-number":["HL065095-25"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 AI152522-05"],"award-info":[{"award-number":["R01 AI152522-05"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mass General Brigham Ventures - Innovation"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Immunotherapy often fails in solid tumors due to an immunosuppressive tumor microenvironment, driven in part by dysfunctional dendritic cells (DC) impairing antigen presentation and suppressive neutrophils. Recent studies revealed a noncanonical role for neutrophils in antigen presentation (nAPC), whose frequency in tumors correlates with improved prognosis in several human cancers. Here, we show that an intravenously delivered antibody\u2013antigen-conjugate (AAC) targeting neutrophil Fc\u03b3RIIIB reprograms neutrophils into nAPCs that drive robust CD8+ T-cell activation. This response requires neutrophils and their expression of major histocompatibility complex class I and occurs independently of conventional type 1 DCs (cDC1), demonstrating that nAPCs can compensate for cDC1 deficiencies. In a mouse melanoma model, AAC therapy promotes durable immunity, limiting metastases of Ova-negative tumors in the lung and contralateral skin, with tumor burden inversely correlating with intratumoral nAPC frequency. AAC treatment efficacy is attributed to tumor infiltration by antigen-specific CD8+ T cells, NK cells, and stem cell-like and tissue-resident memory T cells recognizing both the target antigen and melanocyte-lineage antigens, consistent with effective epitope spreading, which could overcome tumor heterogeneity and antigen loss. Mechanistically, the spleen is required for T-cell priming and tumor infiltration, suggesting AAC engages a cancer\u2013spleen axis that bypasses dysfunctional tumor-draining lymph nodes. Both CD8+ T cells and NK cells are essential for tumor control. Anti\u2013PD-1 co-treatment enhances tumor regression and metastasis control, while anti\u2013PD-1 monotherapy is ineffective. In summary, AAC therapy reprograms neutrophils to initiate potent T-cell immunity, offering a novel strategy to break immune exclusion in solid tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>A novel mechanism of neutrophil reprogramming, utilizing an AAC that initiates antigen presentation in the absence of conventional cDCs, offers a translational strategy to overcome immune exclusion in solid tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0509","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:09:41Z","timestamp":1770660581000},"page":"500-510","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophil Antigen Presentation Reprograms the Tumor Microenvironment and Elicits Durable and Broad Antitumor Immunity"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6448-5397","authenticated-orcid":false,"given":"Huan","family":"Wang","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital Department of Pathology, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-7886","authenticated-orcid":false,"given":"Qi","family":"Meng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital Department of Pathology, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-948X","authenticated-orcid":false,"given":"Yoshimasa","family":"Ito","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital Department of Pathology, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7034-6701","authenticated-orcid":false,"given":"Kanupriya","family":"Kusumakar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital Department of Pathology, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-4457","authenticated-orcid":false,"given":"Tanya","family":"Mayadas","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04b6nzv94","id-type":"ROR","asserted-by":"publisher"}],"name":"Brigham and Women\u2019s Hospital Department of Pathology, , Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"2026030604115780400_bib1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1172\/JCI23049","article-title":"T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells","volume":"115","author":"Zhu","year":"2005","journal-title":"J Clin Invest"},{"key":"2026030604115780400_bib2","doi-asserted-by":"crossref","first-page":"793234","DOI":"10.3389\/fimmu.2022.793234","article-title":"Autoimmunity and cancer-two sides of the same coin","volume":"13","author":"Sakowska","year":"2022","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.autrev.2016.07.032","article-title":"Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases","volume":"15","author":"Garc\u00eda-Gonz\u00e1lez","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2026030604115780400_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fimmu.2016.00481","article-title":"Antigen-presenting cells and antigen presentation in tertiary lymphoid organs","volume":"7","author":"Hughes","year":"2016","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 based immunotherapy of cancer: current perspectives","volume":"9","author":"Thomas","year":"2018","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic dendritic cells in autoimmunity and inflammatory diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol"},{"key":"2026030604115780400_bib7","doi-asserted-by":"crossref","first-page":"1519671","DOI":"10.3389\/fimmu.2024.1519671","article-title":"CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity","volume":"15","author":"Kong","year":"2024","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41584-024-01139-z","article-title":"Advancements and challenges in CAR T cell therapy in autoimmune diseases","volume":"20","author":"Schett","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"2026030604115780400_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","article-title":"Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons","volume":"20","author":"Naimi","year":"2022","journal-title":"Cell Commun Signal"},{"key":"2026030604115780400_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12964-019-0471-y","article-title":"The regulatory roles of neutrophils in adaptive immunity","volume":"17","author":"Li","year":"2019","journal-title":"Cell Commun Signal"},{"key":"2026030604115780400_bib11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fimmu.2017.01781","article-title":"Granulocytes: new members of the antigen-presenting cell family","volume":"8","author":"Lin","year":"2017","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1189\/jlb.1MR1014-502R","article-title":"Neutrophil plasticity: acquisition of phenotype and functionality of antigen-presenting cell","volume":"98","author":"Takashima","year":"2015","journal-title":"J Leukoc Biol"},{"key":"2026030604115780400_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","article-title":"Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer","volume":"30","author":"Singhal","year":"2016","journal-title":"Cancer Cell"},{"key":"2026030604115780400_bib14","doi-asserted-by":"crossref","first-page":"111171","DOI":"10.1016\/j.celrep.2022.111171","article-title":"During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes","volume":"40","author":"Pylaeva","year":"2022","journal-title":"Cell Rep"},{"key":"2026030604115780400_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"2026030604115780400_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ccell.2024.08.008","article-title":"Glioblastoma induces the recruitment and differentiation of dendritic-like \u201chybrid\u201d neutrophils from skull bone marrow","volume":"42","author":"Lad","year":"2024","journal-title":"Cancer Cell"},{"key":"2026030604115780400_bib17","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1046\/j.1523-1755.1999.00446.x","article-title":"Expression of major histocompatibility class II antigens on polymorphonuclear neutrophils in patients with Wegener\u2019s granulomatosis","volume":"55","author":"H\u00e4nsch","year":"1999","journal-title":"Kidney Int"},{"key":"2026030604115780400_bib18","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1046\/j.1523-1755.2001.00068.x","article-title":"Polymorphonuclear neutrophils in Wegener\u2019s granulomatosis acquire characteristics of antigen presenting cells","volume":"60","author":"Iking-Konert","year":"2001","journal-title":"Kidney Int"},{"key":"2026030604115780400_bib19","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/art.11253","article-title":"Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis","volume":"48","author":"Cross","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2026030604115780400_bib20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/ard.2004.034132","article-title":"Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells","volume":"64","author":"Iking-Konert","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2026030604115780400_bib21","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1038\/s41467-021-24591-x","article-title":"Fc\u03b3R engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity","volume":"12","author":"Mysore","year":"2021","journal-title":"Nat Commun"},{"key":"2026030604115780400_bib22","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.4049\/jimmunol.1401018","article-title":"Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells","volume":"193","author":"Davey","year":"2014","journal-title":"J Immunol"},{"key":"2026030604115780400_bib23","doi-asserted-by":"crossref","first-page":"e1007073","DOI":"10.1371\/journal.ppat.1007073","article-title":"An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections","volume":"14","author":"Fites","year":"2018","journal-title":"PLoS Pathog"},{"key":"2026030604115780400_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2249.2002.02008.x","article-title":"Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease","volume":"130","author":"Iking-Konert","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2026030604115780400_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"2026030604115780400_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.trecan.2022.10.006","article-title":"Once upon a prime: DCs shape cancer immunity","volume":"9","author":"Zagorulya","year":"2023","journal-title":"Trends Cancer"},{"key":"2026030604115780400_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2019.00041","article-title":"Regulation of antigen export to the cytosol during cross-presentation","volume":"10","author":"Gros","year":"2019","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"2026030604115780400_bib29","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3389\/fimmu.2019.02393","article-title":"Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications","volume":"10","author":"Fucikova","year":"2019","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","article-title":"Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer","volume":"56","author":"Zagorulya","year":"2023","journal-title":"Immunity"},{"key":"2026030604115780400_bib31","doi-asserted-by":"crossref","first-page":"eabi8800","DOI":"10.1126\/sciimmunol.abi8800","article-title":"Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer","volume":"6","author":"Horton","year":"2021","journal-title":"Sci Immunol"},{"key":"2026030604115780400_bib32","doi-asserted-by":"crossref","first-page":"eabg3551","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci Immunol"},{"key":"2026030604115780400_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"key":"2026030604115780400_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"2026030604115780400_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold tumors: a therapeutic challenge for immunotherapy","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.smim.2015.11.003","article-title":"Reprogramming the tumor microenvironment to enhance adoptive cellular therapy","volume":"28","author":"Beavis","year":"2016","journal-title":"Semin Immunol"},{"key":"2026030604115780400_bib37","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/cancers15133327","article-title":"Circulating and tumor-associated neutrophils in the era of immune checkpoint inhibitors: dynamics, phenotypes, metabolism, and functions","volume":"15","author":"Gibellini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026030604115780400_bib38","first-page":"1890","article-title":"From complexity to consensus: a roadmap for neutrophil classification","volume-title":"Immunity","author":"Ng","year":"2025"},{"key":"2026030604115780400_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.it.2019.05.004","article-title":"Granulopoiesis and neutrophil homeostasis: a metabolic, daily balancing act","volume":"40","author":"Yvan-Charvet","year":"2019","journal-title":"Trends Immunol"},{"key":"2026030604115780400_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0092-8674(94)90115-5","article-title":"FcR gamma chain deletion results in pleiotrophic effector cell defects","volume":"76","author":"Takai","year":"1994","journal-title":"Cell"},{"key":"2026030604115780400_bib41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2008.04.013","article-title":"Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases","volume":"28","author":"Tsuboi","year":"2008","journal-title":"Immunity"},{"key":"2026030604115780400_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nmeth.3322","article-title":"Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes","volume":"12","author":"Hasenberg","year":"2015","journal-title":"Nat Methods"},{"key":"2026030604115780400_bib43","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1182\/blood.V114.22.2404.2404","article-title":"3G8 and GMA161, anti Fc\u03b3RIII inhibitory monoclonal antibodies in the treatment of chronic refractory ITP (summary of 2 pilot studies)","volume":"114","author":"Nakar","year":"2009","journal-title":"Blood"},{"key":"2026030604115780400_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/gene.10056","article-title":"A conditional null allele of the major histocompatibility IA-beta chain gene","volume":"32","author":"Hashimoto","year":"2002","journal-title":"Genesis"},{"key":"2026030604115780400_bib45","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"2026030604115780400_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"2026030604115780400_bib47","doi-asserted-by":"crossref","first-page":"e20230699","DOI":"10.1084\/jem.20230699","article-title":"Framework for in vivo T cell screens","volume":"221","author":"Milling","year":"2024","journal-title":"J Exp Med"},{"key":"2026030604115780400_bib48","doi-asserted-by":"crossref","first-page":"eaaz2738","DOI":"10.1126\/sciimmunol.aaz2738","article-title":"NK cells mediate clearance of CD8+ T cell-resistant tumors in response to STING agonists","volume":"5","author":"Nicolai","year":"2020","journal-title":"Sci Immunol"},{"key":"2026030604115780400_bib49","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","article-title":"The spleen in local and systemic regulation of immunity","volume":"39","author":"Bronte","year":"2013","journal-title":"Immunity"},{"key":"2026030604115780400_bib50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2026030604115780400_bib51","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20161621","article-title":"Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of S. pneumoniae","volume":"214","author":"Deniset","year":"2017","journal-title":"J Exp Med"},{"key":"2026030604115780400_bib52","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ni.3197","article-title":"Batf3 maintains autoactivation of Irf8 for commitment of a CD8\u03b1(+) conventional DC clonogenic progenitor","volume":"16","author":"Grajales-Reyes","year":"2015","journal-title":"Nat Immunol"},{"key":"2026030604115780400_bib53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"2026030604115780400_bib54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"2026030604115780400_bib55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"2026030604115780400_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"2026030604115780400_bib57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fimmu.2020.00275","article-title":"Unleashing natural killer cells in the tumor microenvironment-the next generation of immunotherapy?","volume":"11","author":"Ben-Shmuel","year":"2020","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib58","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41590-020-0786-2","article-title":"BATF3 programs CD8+ T cell memory","volume":"21","author":"Ataide","year":"2020","journal-title":"Nat Immunol"},{"key":"2026030604115780400_bib59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4049\/jimmunol.2000228","article-title":"Cutting edge: Batf3 expression by CD8 T cells critically regulates the development of memory populations","volume":"205","author":"Qiu","year":"2020","journal-title":"J Immunol"},{"key":"2026030604115780400_bib60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jimmun\/vkaf035","article-title":"Lung-resident memory CD4+ T cells are dependent on Batf3","volume":"214","author":"Patterson","year":"2025","journal-title":"J Immunol"},{"key":"2026030604115780400_bib61","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41588-023-01554-0","article-title":"Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens","volume":"55","author":"McCutcheon","year":"2023","journal-title":"Nat Genet"},{"key":"2026030604115780400_bib62","doi-asserted-by":"crossref","first-page":"e1007797","DOI":"10.1371\/journal.ppat.1007797","article-title":"NK cell-intrinsic Fc\u03b5RI\u03b3 limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection","volume":"15","author":"Duhan","year":"2019","journal-title":"PLoS Pathog"},{"key":"2026030604115780400_bib63","doi-asserted-by":"crossref","first-page":"1213629","DOI":"10.3389\/fimmu.2023.1213629","article-title":"Impaired function of dendritic cells within the tumor microenvironment","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Immunol"},{"key":"2026030604115780400_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2018.03.025","article-title":"Dysfunction of antigen processing and presentation by dendritic cells in cancer","volume":"113","author":"Bandola-Simon","year":"2019","journal-title":"Mol Immunol"},{"key":"2026030604115780400_bib65","doi-asserted-by":"crossref","first-page":"1511560","DOI":"10.3389\/fonc.2025.1511560","article-title":"Expanding horizons of cancer immunotherapy: hopes and hurdles","volume":"15","author":"Sonar","year":"2025","journal-title":"Front Oncol"},{"key":"2026030604115780400_bib66","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.2300049","article-title":"Memory T cells in the immunoprevention of cancer: a switch from therapeutic to prophylactic approaches","volume":"211","author":"Mittra","year":"2023","journal-title":"J Immunol"},{"key":"2026030604115780400_bib67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41385-021-00467-7","article-title":"Human mucosal tissue-resident memory T cells in health and disease","volume":"15","author":"Lange","year":"2022","journal-title":"Mucosal Immunol"},{"key":"2026030604115780400_bib68","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"key":"2026030604115780400_bib69","doi-asserted-by":"crossref","first-page":"e20201605","DOI":"10.1084\/jem.20201605","article-title":"Tissue-resident memory T cells in tumor immunity and immunotherapy","volume":"218","author":"Okla","year":"2021","journal-title":"J Exp Med"},{"key":"2026030604115780400_bib70","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","article-title":"The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies","volume":"21","author":"Bald","year":"2020","journal-title":"Nat Immunol"},{"key":"2026030604115780400_bib71","doi-asserted-by":"crossref","first-page":"17634","DOI":"10.3390\/ijms242417634","article-title":"Breakthroughs in cancer immunotherapy: an overview of T cell, NK cell, M\u03c6, and DC-based treatments","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026030604115780400_bib72","doi-asserted-by":"crossref","first-page":"eabd8636","DOI":"10.1126\/scitranslmed.abd8636","article-title":"Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses","volume":"13","author":"Lo","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026030604115780400_bib73","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM198605083141907","article-title":"Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody","volume":"314","author":"Clarkson","year":"1986","journal-title":"N Engl J Med"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0509\/3736552\/crc-25-0509.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/3\/500\/3746064\/crc-25-0509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/3\/500\/3746064\/crc-25-0509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:12:13Z","timestamp":1772788333000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/3\/500\/775147\/Neutrophil-Antigen-Presentation-Reprograms-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0509","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32729485","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729497","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729488","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729494","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729515","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729506","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729512","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729500","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729503","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729509","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32729491","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8545243","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}